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The Burning Month Syndrome (BMS) is an oral mucosa 
pain - with or without inflammatory signs - without any 
specific lesion. It is mostly observed in women aged 40-60 
years. This pain feels like a moderate/severe burning, and 
it occurs more frequently on the tongue, but it may also be 
felt at the gingiva, lips and jugal mucosa. It may worsen 
during the day, during stress and fatigue, when the patient 
speaks too much, or through eating of spicy/hot foods. The 
burning can be diminished with cold food, work and leisure. 
The goal of this review article is to consider possible BMS 
etiologies and join them in 4 groups to be better studied: local, 
systemic, emotional and idiopathic causes of pain. Knowing 
the different diagnoses of this syndrome, we can establish 
a protocol to manage these patients. Within the local pain 
group, we must investigate dental, allergic and infectious 
causes. Concerning systemic causes we need to look for 
connective tissue diseases, endocrine disorders, neurological 
diseases, nutritional deficits and salivary glands alterations 
that result in xerostomia. BMS etiology may be of difficult 
diagnosis, many times showing more than one cause for oral 
pain. A detailed interview, general physical examination, oral 
cavity and oropharynx inspection, and lab exams are essential 
to avoid a try and error treatment for these patients.
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INTRODUCTION
Burning Mouth Syndrome (BMS) is characterized 
by pain in the mouth with or with no inflammatory signs 
and no specific lesions. Synonyms found in literature 
include glossodynia, oral dysesthesia, glossopyrosis, 
glossalgia, stomatopyrosis, and stomatodynia1-4. It usually 
affects women aged between 40 and 60 years and the 
prevalence in the general population is 3.7% (1.6% men 
and 5.5% women)5.
BMS generally presents as a triad: mouth pain, al-
teration in taste, and altered salivation, in the absence of 
visible mucosal lesions in the mouth3.
Pain is a moderate to severe burning sensation, af-
fecting mainly the lateral borders and the tip of the tongue, 
and may persist for years. Pain may also be present in the 
gums, the lips and the jugal mucosa, with no visible lesions 
on oral and pharyngeal examination. Pain increases as 
the day progresses, in states of anxiety, fatigue, excessive 
speaking, and when ingesting hot and seasoned food; pain 
subsides with cold food, work and distraction3,6. Burning 
in the mouth does not match the anatomy of peripheral 
nerves and typically affects more than one site.
In 1994 Lamey et al.7, in an attempt to group dif-
ferent types of patients, divided the syndrome into three 
types (Chart 1): Type 1 (35%), defined by daily pain where 
symptoms are absent upon awakening but gradually 
increase in severity as the day progresses, unrelated to 
psychiatric conditions. Type 2 (55%) is defined by constant 
pain day and night; these patients are very anxious. Type 
3 (10%) is defined by intermittent pain, with pain free 
intervals, occurring in non-usual sites such as the floor of 
mouth and the posterior oropharynx; in this type there 
is a relation between pain and the type of food taken as 
well as allergens.
Stinging on the lips and mouth or intense salivation 
are common symptoms. Alterations in salivary content 
have been detected such as increased content of potas-
sium, proteins and phosphates, making saliva thicker 
and stickier. Another important symptom is hypogeusia 
or dysgeusia, in which patients complain of a persistent 
metallic, salty or bitter taste3.
The etiology of BMS is difficult to define, and 
there may be more than one etiological factor. Patients 
seek help from a variety of medical specialists, including 
dentists, ENT specialists, and dermatologists, and try a 
range of therapies, the most common of which are: corti-
costeroids, analgesics, antibiotics, estrogen, retinoids and 
psychotropic drugs8.
A careful clinical history, a general physical ex-
amination, a detailed examination of the mouth and oro-
pharynx are mandatory to avoid trial and error treatment 
of this syndrome.
The aim of this review is to provide an overview 
of possible etiologies of BMS, grouping them into 4 major 
groups for better understanding (Chart 2): local, systemic, 
emotional and idiopathic mouth pain. Based on the dif-
ferential diagnosis of this syndrome, we suggest a protocol 
to manage these patients.
Chart 1. Classification of BMS subtypes7
Clinical findings Association
Type 1
Daily pain, not present upon 
awakening, worsens as the 
day progresses
Non-psychiatric
Type 2 Constant pain Psychiatric, chronic anxiety
Type 3
Intermittent pain in unusual 
sites (floor of mouth)
Allergic contact stomatitis 
due to preserving agents 
and additives
Chart 2. Etiology of BMS
Systemic Local Psychogenic Idiopathic
Salivary gland alte-
ration
(Sjögren, FM, medica-
tion, irradiation, anxie-
ty or stress)
Dental
(prosthesis, 
trauma, pa-
rafunctional 
behavioral al-
terations)
Depression, 
anxiety, can-
cerphobia,
OCD
-----
Endocrine
(DM, hypothyroidism, 
menopause)
Allergy
(additives, co-
loring agents, 
p r e s e r v i n g 
agents, food)
----- -----
Medication
(ACEi, ATB, anti-re-
troviral drugs, antide-
pressants (tricyclic)
Infectious
(candida, no-
specific bac-
teria, fusospi-
rochetes)
----- -----
Neurological
(trigeminal and glos-
sopharyngeal neu-
ralgia)
----- ----- -----
Nutritional
(iron, B vitamin com-
plex, folic acid and 
zinc)
----- ----- -----
(FM) fibromyalgia, (DM) diabetes mellitus, (ACEi) angiotensin-convert-
ing enzyme inhibitor, (ATB) antibiotic, (OCD) obsessive compulsive 
disorder.
REVIEW OF LITERATURE
A - Local causes
Dental
Pain in the mouth may appear due to incorrect 
use of orthodontic appliances, ill-positioned or corroded 
dental fixtures, and fixtures used for a very long time, with 
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the patient complaining of a metallic taste. Local reaction 
caused by contact between the mucosa and metal leads to 
erythema and a burning sensation. Currently local irritation 
may also be caused by tongue piercing.
There may be local pain by mechanical trauma in 
patients that repeatedly bite the jugal mucosa due to dental 
problems or malocclusion.
Having discarded orofacial pain of dental causes, 
which is the most common form, parafunctional habits 
and behaviors should be investigated, such as temporo-
mandibular joint (TMJ)9 problems. The main complaints 
are TMJ crepitation, local pain, and referred pain to the 
ear or mouth. Patients with miofacial pain, bruxism, large 
tongues or that press the tongue against the teeth may 
also have tongue pain.
Allergic
Allergy to food coloring agents, preservatives and 
additives has been identified in 65% of type 3 BMS patients 
(intermittent pain, with pain free periods, in non-usual 
sites). Substances identified as commonly causing mouth 
pain are: cinnamon aldehyde, ascorbic acid, tartarazine, 
benzoic acid, propyleneglycol and menthol7. Food such as 
shrimp, nuts, fish and chocolate may cause sudden onset 
allergy, with edema and pruritus usually on the tongue. 
Severe allergy cases usually are caused by drugs such as 
sulphonamides, antibiotics, non-steroidal anti-inflamma-
tory medication and analgesics.
Allergy to denture materials is rare, and should be 
considered only after confirmation by allergy tests which 
correlate to clinical findings4,10.
Infectious
Candida
The causal agent is Candida albicans, and it appears 
in the elderly, in immunodeficient patients, in prolonged 
use of antibiotics, immunosuppressant medication, anti-
retroviral drugs or corticosteroids. Candida infection may 
present with or with no inflammation on the mucosa, and 
patients refer burning in the mouth resulting in dysphagia 
and sialorrhea2. Burning is due to multiplication of candida. 
Detection of pain stimuli takes place at sensorial nerve 
terminations called nocireceptors. These small diameter 
neurons translate mechanical, chemical and temperature 
variation signals to the central nervous system, giving us 
the perception of pain or discomfort, acting by means of 
the receptor capsaicin (vanilloid)11.
Dental fixtures also help increase the number of 
fungal colonies11.
Non-specific bacteria
This is dental conservation related infection. Caus-
ative agents are the polymicrobial oral flora saprophytes 
including streptococci, enterococci, staphylococci, neis-
seria, proteus, anaerobes and fusospiral organisms. Many 
infections are opportunistic. There is gingival congestion 
and edema of interdental papillae, there may be hyperemia 
of the mouth mucosa and tongue, which may show inden-
tation marks along its lateral borders. Pain and halitosis 
are intense in more advanced cases12.
B - Systemic causes
Alteration of salivary glands
Salivary gland function is altered by a variety of 
drugs that induce xerostomia, which affects eating and 
the capability to resist bacterial colonization of the teeth, 
and which may alter the taste.
Many drugs may alter salivary gland function, the 
most common being anticholinergic agents, anti-his-
tamines, anti-retroviral drugs, tricyclic antidepressants, 
serotonin uptake inhibitors and omeprazol13.
Xerostomia depends on the drug, the dose and 
individual patient differences. Burning may develop days 
to years after exposure to the causative agent13.
Chemotherapy agents, such as adriamycin, cause 
mucositis 5 to 7 days after the initial dose. The patient 
presents intense local pain in the oral mucosa, and if 
chemotherapy is maintained, may develop reduced sali-
vary flow and gland destruction. Normally the gingiva, 
the dorsal surface of the tongue and the hard palate are 
not involved14.
Radiotherapy (RT) may initially cause mucositis and 
increased salivary flow due to local inflammation. At this 
moment the mucosa is extremely painful. If RT is main-
tained there may be permanent mucosal atrophy, causing 
burning on the tongue, dry mouth and swallowing diffi-
culty. Salivary gland function is compromised depending 
on the radiation dose; irradiation over 40Gy/dose causes 
irreversible gland injury15. pH falls significantly from normal 
values to 6.7514.
Medication
There are many description in literature of glos-
sitis in patients taking ACE inhibitors13,16,17. Anti-retroviral 
drugs, antibiotics (cephalosporins, chloramphenicol, 
penicillin, gabapentin), tricyclic antidepressants and anti-
anxiety drugs are also cited as causing mouth pain13. The 
pain inducing mechanism with no xerostomia is not well 
known.
Connective tissue diseases
Sjögren’s syndrome is an autoimmune disease affect-
ing mostly women aged between 40 and 60 years, and may 
be associated with other connective tissue disorders such 
as multiple sclerosis and rheumatoid arthritis. The classi-
cal presentation of this syndrome is keratoconjunctivitis, 
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xerostomia and connective tissues alterations.
Fibromyalgia (FM) is a chronic pain syndrome usu-
ally diagnosed based on the presence of pain in at least 11 
of 18 tender points lasting at least 3 months. BMS is seen in 
32.8% of FM patients, where the most frequently described 
oral symptoms include xerostomia (70.9%), orofacial pain 
(32.8%), TMJ dysfunction (67.6%), dysphagia (37.3%), and 
dysgeusia (34,2%)18.
Endocrine
BMS may signal undiagnosed diabetes mellitus 
(DM), therefore DM should be investigated particularly in 
patients aged over 50 years, when the incidence of type II 
DM is increased11. Other pain mechanisms in the mouth 
that should be considered for diabetic patients include 
candida infection and diabetic neuropathy19.
There is controversy in literature on the role of estro-
gens as an oral mucosa protective factor. Although mouth 
pain has a high incidence in post-menopausal women, 
studies have not found a significant relationship between 
mouth pain and the number of menopausal years, the use 
of hormone replacement therapy of the number of years 
of hormone replacement20.
Neurological
Pain stimuli are detected by nocireceptors, receptors 
with capsaicin21. Petruzzi et al., in a comparative, triple 
blind study, observed that following capsaicin use during 
4 weeks, there was a reduction in mouth pain in 84% of 
patients, compared to controls. The therapeutic efficacy 
of capsaicin strengthens the hypothesis that there is a 
neurogenic cause of BMS.
Further evidence that BMS may have a neurogenic 
origin is that these patients have thermal hypersensitivity 
and significant electrophysiological abnormalities com-
pared to controls22.
Trigeminal neuralgia
Trigeminal neuralgia is characterized by brief epi-
sodes of intense pain in bursts, usually in people aged 
over 50 years, mainly involving the mandibular branch 
territory, sometimes causing tongue hypoesthesia or par-
esthesia. Trigeminal neuralgia may be caused by nerve 
compression due to neoplasms, vascular malformation, 
encephalopathy, myringomyelia, herpes zoster infection, 
trauma or after dental extraction15.
Glossopharyngeal neuralgia
Glossopharyngeal neuralgia is a rare disease occur-
ring mostly in women aged between 40 and 60 years23. Pain 
is usually incapacitating, unilateral, affecting the posterior 
oropharynx, tonsillar fossa and base of the tongue, ex-
tending to the ear. It is initiated by swallowing, coughing 
or phonation24.
Pain may also be caused by undiagnosed neo-
plasms, infection, elongated styloid process and vascular 
causes such as arterial compression, elongation or looping, 
mostly of the posterior inferior cerebellar artery24. Neuralgia 
may course with bradycardia, asystole and syncope in up 
to 10% of cases15.
Nutritional deficiencies
A burning sensation on the tongue may occur in 
40% of patients with vitamin B deficiency. Tongue pain is 
usually located on the tip of the tongue, and patients may 
present papillary atrophy. Patients undergoing hemody-
alisis or that restrict their diet in some way (vegetarians, 
lactose-free diet), alcoholics and the elderly are prone to 
vitamin B deficiency15.
Zinc deficiency may cause organic effects such as 
lingual papillary atrophy, resulting in dysgeusia and gloss-
odynia. Tanaka et al.25 noted improvement in symptoms 
following zinc intake and further clinical improvement 
when zinc was associated with B12 vitamin and iron.
C - Emotional
Zeller et al.8 found up to a 30% psychiatric disorder 
associated with BMS, including depression, anxiety, ob-
session, panic syndrome and fear of cancer2.2,26 Hakeberg 
et al.,1 focusing psychological aspects of women with 
BMS, observed that all patients in their study had gone 
through situations of great stress or disappointment in 
their lives, culminating with the appearance of mouth 
pain. These authors also found that these women were 
very anxious and described themselves as persistent and 
self-demanding. Vitkov et al.11 believe that BMS patients 
have a reduced pain threshold, and this threshold is lower 
still in women.
D - Idiopathic
This is when careful local, systemic and emotional 
investigation fails to reveal an etiology for BMS.
BMS-RELATED ANATOMICAL VARIATIONS
1- Lingua plicata
After age four, the tongue may develop grooves in 
some people, with folds in the anterior two thirds of the 
tongue. A burning sensation may ensue when there is in-
flammation along these grooves caused by ingesting acid 
and/or very seasoned food. These grooves may be entry 
portals for infection such as herpes simplex, candida and 
syphilis. This may also be part of Melkerson Rosenthal’s 
syndrome, which progresses with granulomatous glossitis, 
facial palsy, lingua plicata and lip edema.
It is found in 30% of Down syndrome patients15.
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2 - Geographic tongue
Geographic tongue is characterized by areas of pink 
mucosa with a grayish center. These areas may converge 
and are interspaced with normal mucosa. This condition is 
a benign condition, not a disease. Patients with this lingual 
alteration may be prone to cancerphobia. Psychological 
(stress) and local (allergies) reactions are believed to cause 
this condition, as well as genetic factors. Usually areas of 
altered mucosa increase when there is some other parallel 
medical condition15. Altered mucosa in this condition is 
more sensitive to very salty, seasoned or sour food, which 
may cause pain in the mouth.
MANAGEMENT OF PATIENTS WITH BMS
BMS is usually multifactorial, and these patients 
require an organized approach to take the various etiolo-
gies into account.
The history of pain should be established, including 
duration, intensity (on a 1 to 10 scale), site, and factors 
that improve or worsen the pain. Inquiries should also 
be made about increased salivation, dry mouth, altered 
taste, the diet, the use or oral antiseptics, the type of 
toothpaste, habits such as chewing gum, smoking, and 
taking alcoholic beverages. Other information includes 
any relation between pain and the use of dental fixtures 
and prostheses, parafunctional behavior (bruxism, tongue 
compression between teeth), and the use of medication 
and its xerostomia causing potential. A psychological his-
tory is also extremely relevant, including questions about 
anxiety, depression and cancerphobia.
A detailed general and oral physical examination 
should be made, to uncover the presence of erythema, 
glossitis, lingual papilla atrophy, sings of tongue biting, 
candida infection, lingua plicata, geographic tongue, lichen 
planus or xerostomia.
Work-up should include a complete blood count, 
TSH, free T4, fasting blood glucose, iron, ferritin, transferrin 
and folic acid. Diabetics should also be tested for glycosyl-
ated hemoglobin to check if diabetes is well controlled. 
Rheumatologic and autoimmune tests may be required if 
warranted by the clinical history3. Candida cultures are 
unnecessary as this fungus is part of the normal oral flora; 
treatment may be given empirically. If food allergy is sus-
pected, patch testing may be needed. Drage et al.4 recom-
mends allergic tests in all BMS cases. Electrogustometry 
may be used to verify salivary flow and content.
Patients with psychological conditions should be 
referred to a psychiatrist who will assess any relation be-
tween the onset of symptoms and events in the patients’ 
lives such as intense stress, loss of loved relatives, fear of 
cancer, etc. A dental evaluation should also be done to 
recommend improved dental care and adequate use of 
dental fixtures.
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